199 related articles for article (PubMed ID: 36585408)
1. Effects of acute estradiol and progesterone on perimenstrual exacerbation of suicidal ideation and related symptoms: a crossover randomized controlled trial.
Eisenlohr-Moul TA; Bowers SM; Prinstein MJ; Schmalenberger KM; Walsh EC; Young SL; Rubinow DR; Girdler SS
Transl Psychiatry; 2022 Dec; 12(1):528. PubMed ID: 36585408
[TBL] [Abstract][Full Text] [Related]
2. Effects of estrogen and progesterone on neuroactive steroids and cytokines in patients with suicidality.
Barone JC; Wenzel E; Alluri V; Moriarity D; Pinna G; Walsh E; Rubinow DR; Morrow AL; Eisenlohr-Moul TA
Psychoneuroendocrinology; 2023 Nov; 157():106359. PubMed ID: 37611527
[TBL] [Abstract][Full Text] [Related]
3. Predicting Acute Changes in Suicidal Ideation and Planning: A Longitudinal Study of Symptom Mediators and the Role of the Menstrual Cycle in Female Psychiatric Outpatients With Suicidality.
Ross JM; Barone JC; Tauseef H; Schmalenberger KM; Nagpal A; Crane NA; Eisenlohr-Moul TA
Am J Psychiatry; 2024 Jan; 181(1):57-67. PubMed ID: 38093647
[TBL] [Abstract][Full Text] [Related]
4. Cyclical exacerbation of suicidal ideation in female outpatients: Prospective evidence from daily ratings in a transdiagnostic sample.
Owens SA; Schmalenberger KM; Bowers S; Rubinow DR; Prinstein MJ; Girdler SS; Eisenlohr-Moul TA
J Psychopathol Clin Sci; 2023 Aug; 132(6):704-715. PubMed ID: 37326562
[TBL] [Abstract][Full Text] [Related]
5. Perimenstrual exacerbation of symptoms in borderline personality disorder: evidence from multilevel models and the Carolina Premenstrual Assessment Scoring System.
Eisenlohr-Moul TA; Schmalenberger KM; Owens SA; Peters JR; Dawson DN; Girdler SS
Psychol Med; 2018 Sep; 48(12):2085-2095. PubMed ID: 29804553
[TBL] [Abstract][Full Text] [Related]
6. The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback.
Nguyen TV; Reuter JM; Gaikwad NW; Rotroff DM; Kucera HR; Motsinger-Reif A; Smith CP; Nieman LK; Rubinow DR; Kaddurah-Daouk R; Schmidt PJ
Transl Psychiatry; 2017 Aug; 7(8):e1193. PubMed ID: 28786978
[TBL] [Abstract][Full Text] [Related]
7. Histories of abuse predict stronger within-person covariation of ovarian steroids and mood symptoms in women with menstrually related mood disorder.
Eisenlohr-Moul TA; Rubinow DR; Schiller CE; Johnson JL; Leserman J; Girdler SS
Psychoneuroendocrinology; 2016 May; 67():142-52. PubMed ID: 26896670
[TBL] [Abstract][Full Text] [Related]
8. Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
Naheed B; Kuiper JH; Uthman OA; O'Mahony F; O'Brien PM
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010503. PubMed ID: 28257559
[TBL] [Abstract][Full Text] [Related]
9. Differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphoric disorder.
Thys-Jacobs S; McMahon D; Bilezikian JP
J Clin Endocrinol Metab; 2008 Jan; 93(1):96-102. PubMed ID: 17956950
[TBL] [Abstract][Full Text] [Related]
10. Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.
Schmidt PJ; Martinez PE; Nieman LK; Koziol DE; Thompson KD; Schenkel L; Wakim PG; Rubinow DR
Am J Psychiatry; 2017 Oct; 174(10):980-989. PubMed ID: 28427285
[TBL] [Abstract][Full Text] [Related]
11. Treatment of premenstrual dysphoric disorder with the GABA
Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
[TBL] [Abstract][Full Text] [Related]
12. Changes in premenstrual symptoms in women with schizophrenia: a prospective study.
Choi SH; Kang SB; Joe SH
Psychosom Med; 2001; 63(5):822-9. PubMed ID: 11573031
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial.
Canning S; Waterman M; Orsi N; Ayres J; Simpson N; Dye L
CNS Drugs; 2010 Mar; 24(3):207-25. PubMed ID: 20155996
[TBL] [Abstract][Full Text] [Related]
14. Secretory dynamics of oestradiol (E2) and progesterone (P4) during periods of relative pituitary LH quiescence in the midluteal phase of the menstrual cycle.
Rossmanith WG; Laughlin GA; Mortola JF; Yen SS
Clin Endocrinol (Oxf); 1990 Jan; 32(1):13-23. PubMed ID: 2331809
[TBL] [Abstract][Full Text] [Related]
15. Frequency of luteinizing hormone pulses in cattle influences duration of persistence of dominant ovarian follicles, follicular fluid concentrations of steroids, and activity of insulin-like growth factor binding proteins.
Kojima FN; Bergfeld EG; Wehrman ME; Cupp AS; Fike KE; Mariscal-Aguayo DV; Sanchez-Torres T; Garcia-Winder M; Clopton DT; Roberts AJ; Kinder JE
Anim Reprod Sci; 2003 Jul; 77(3-4):187-211. PubMed ID: 12695054
[TBL] [Abstract][Full Text] [Related]
16. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
Cerbo AD
Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
[TBL] [Abstract][Full Text] [Related]
17. Sublingual administration of micronized estradiol and progesterone, with and without micronized testosterone: effect on biochemical markers of bone metabolism and bone mineral density.
Miller BE; De Souza MJ; Slade K; Luciano AA
Menopause; 2000; 7(5):318-26. PubMed ID: 10993031
[TBL] [Abstract][Full Text] [Related]
18. In vitro follicular and luteal steroidogenesis in the pregnant hamster with preliminary studies in the rat.
Greenwald GS; Voogt JL; Limback D
Biol Reprod; 1984 Feb; 30(1):93-104. PubMed ID: 6696967
[TBL] [Abstract][Full Text] [Related]
19. Varying levels of serum estradiol do not alter the timing of the early endometrial secretory transformation.
Osman EK; Wang T; Zhan Y; Juneau CR; Morin SJ; Seli E; Scott RT; Franasiak JM
Hum Reprod; 2020 Jul; 35(7):1637-1647. PubMed ID: 32613240
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2, prostaglandin F2 alpha and endothelin-1 production by cow oviductal epithelial cell monolayers: effect of progesterone, estradiol 17 beta, oxytocin and luteinizing hormone.
Wijayagunawardane MP; Miyamoto A; Sato K
Theriogenology; 1999 Oct; 52(5):791-801. PubMed ID: 10735120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
